HIV-1 virologic failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya: a cross-sectional study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-6405
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
HIV-1 virologic failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya: a cross-sectional study ; volume:11 ; number:1 ; day:23 ; month:1 ; year:2014 ; pages:1-12 ; date:12.2014
AIDS research and therapy ; 11, Heft 1 (23.1.2014), 1-12, 12.2014
- Urheber
-
Hassan, Amin S.
Nabwera, Helen M.
Mwaringa, Shalton M.
Obonyo, Clare A.
Sanders, Eduard J.
Rinke de Wit, Tobias F.
Cane, Patricia A.
Berkley, James A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1742-6405-11-9
- URN
-
urn:nbn:de:101:1-2019063009342493862872
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hassan, Amin S.
- Nabwera, Helen M.
- Mwaringa, Shalton M.
- Obonyo, Clare A.
- Sanders, Eduard J.
- Rinke de Wit, Tobias F.
- Cane, Patricia A.
- Berkley, James A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon
Virologic response of treatment experienced HIV-infected Ugandan children and adolescents on NNRTI based first-line regimen, previously monitored without viral load
Virologic suppression in response to antiretroviral therapy despite extensive resistance within HIV-1 reverse transcriptase after the first virologic failure
Prevalence of HIV drug-resistance mutations in HIV-infected Mexican patients heavily experienced to antiretroviral therapy
Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients
First-line antiretroviral treatment and virological response among HIV adult patients at an accredited HIV care center, Cameroon
Clinical and paraclinical aspects of HIV infected patients with first-line antiretroviral regimens
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance
HIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from Northwestern Poland
Molecular epidemiology of antiretroviral resistance in therapy-experienced HIV-1 patients in Cuba (2009)
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon
Virologic response of treatment experienced HIV-infected Ugandan children and adolescents on NNRTI based first-line regimen, previously monitored without viral load
Virologic suppression in response to antiretroviral therapy despite extensive resistance within HIV-1 reverse transcriptase after the first virologic failure
Prevalence of HIV drug-resistance mutations in HIV-infected Mexican patients heavily experienced to antiretroviral therapy
Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients
First-line antiretroviral treatment and virological response among HIV adult patients at an accredited HIV care center, Cameroon
Clinical and paraclinical aspects of HIV infected patients with first-line antiretroviral regimens
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance
HIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from Northwestern Poland
Molecular epidemiology of antiretroviral resistance in therapy-experienced HIV-1 patients in Cuba (2009)
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon
Virologic response of treatment experienced HIV-infected Ugandan children and adolescents on NNRTI based first-line regimen, previously monitored without viral load
Virologic suppression in response to antiretroviral therapy despite extensive resistance within HIV-1 reverse transcriptase after the first virologic failure
Prevalence of HIV drug-resistance mutations in HIV-infected Mexican patients heavily experienced to antiretroviral therapy
Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients
First-line antiretroviral treatment and virological response among HIV adult patients at an accredited HIV care center, Cameroon
Clinical and paraclinical aspects of HIV infected patients with first-line antiretroviral regimens
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance
HIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from Northwestern Poland